BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26972419)

  • 1. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
    Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
    Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
    Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
    Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.
    Trabzonlu L; Muezzinoglu B; Corakci A
    Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1α, adrenomedullin and Bcl-2 although expected are not related to increased uptake of fluorine-18-fluorodeoxyglucose in endometrial cancer.
    Cerci SS; Yalcin Y; Bozkurt KK; Erdemoglu E; Tatar B; Erdemoglu E
    Hell J Nucl Med; 2015; 18(3):228-32. PubMed ID: 26637502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
    Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenomedullin, Bcl-2 and microvessel density in normal, hyperplastic and neoplastic endometrium.
    Nunobiki O; Nakamura M; Taniguchi E; Utsunomiya H; Mori I; Tsubota Y; Mabuchi Y; Kakudo K
    Pathol Int; 2009 Aug; 59(8):530-6. PubMed ID: 19627536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
    Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG
    Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of Bcl-2 expression in normal endometrium and endometrial carcinoma].
    Zheng Y; Peng Z; Wang H
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):92-5. PubMed ID: 12205937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
    Shroyer KR; Stephens JK; Silverberg SG; Markham N; Shroyer AL; Wilson ML; Enomoto T
    Int J Gynecol Pathol; 1997 Jul; 16(3):225-32. PubMed ID: 9421087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
    Zhou WX; Liang ZY; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Hum Reprod; 2001 Oct; 16(10):2211-8. PubMed ID: 11574518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
    Guo ZL; Chen K; Wang XQ; Hu W
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium.
    Cinel L; Polat A; Aydin O; Düşmez D; Eğilmez R
    Pathol Int; 2002; 52(5-6):384-9. PubMed ID: 12100521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.